Skip to main content
Log in

The Impact of Different DCE-Based Approaches When Anchoring Utility Scores

  • Original Research Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Abstract

Background

Discrete choice experiments (DCEs) have been proposed as a method to estimate utility weights for health states within utility instruments. However, the most appropriate method to anchor the utility values on the full health to dead quality-adjusted life year (QALY) scale remains uncertain. We test four approaches to anchoring in which dead is valued at zero and full health at one.

Methods

We use data from two DCEs valuing EQ-5D-3L and EQ-5D-5L health states, which presented pairs of health profiles with an associated duration, and a dead option. The approaches to anchoring the results on the required scale were (1) using only preferences between non-dead health profiles; (2) including the dead data, treating it as a health profile with zero duration; (3) explicitly modelling both duration and dead; and (4) using the preferences regarding the dead health state as an external anchor subsequent to the estimation of approach 1.

Results

All approaches lead to differences in the scale of utility decrements, but not the ranking of EQ-5D health states. The models differ in their ability to predict preferences around dead health states, and the characteristics of the value sets in terms of their range and the proportion of states valued as worse than dead.

Discussion

Appropriate anchoring of DCEs with or without complementary time trade-off (TTO) data remains unresolved, and the method chosen will impact on health resource allocation decision making employing the value sets.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. de Bekker-Grob EW, Ryan M, Gerard K. Discrete choice experiments in health economics: a review of the literature. Health Econ. 2012;21(2):145–72.

    Article  PubMed  Google Scholar 

  2. Bansback N, Brazier J, Tsuchiya A, Anis A. Using a discrete choice experiment to estimate societal health state utility values. J Health Econ. 2012;31:306–18. doi:10.1016/j.jhealeco.2011.11.004.

    Article  PubMed  Google Scholar 

  3. Norman R, Cronin P, Viney R. A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states. Appl Health Econ Health Policy. 2013;11(3):287–98.

    Article  PubMed  Google Scholar 

  4. Norman R, Viney R, Brazier J, Burgess L, Cronin P, King MT, et al. Valuing SF-6D health states using a discrete choice experiment. Med Decis Making. 2014;34(6):773–86.

    Article  PubMed  Google Scholar 

  5. Stolk EA, Oppe M, Scalone L, Krabbe PFM. Discrete choice modeling for the quantification of health states: the case of the EQ-5D. Value Health. 2010;13(8):1005–13.

    Article  PubMed  Google Scholar 

  6. Viney R, Norman R, Brazier J, Cronin P, King MT, Ratcliffe J, et al. An Australian discrete choice experiment to value eq-5d health States. Health Econ. 2014;23(6):729–42. doi:10.1002/hec.2953.

    Article  PubMed  Google Scholar 

  7. Bleichrodt N, Wakker P, Johannesson M. Characterizing QALYs by risk neutrality. J Risk Uncertain. 1997;15(2):107–14.

    Article  Google Scholar 

  8. McFadden D. Conditional logit analysis of qualitative choice behaviour. In: Zarembka P, editor. Frontiers in econometrics. New York: New York Academic Press; 1974. p. 105–42.

    Google Scholar 

  9. Thurstone LL. A law of comparative judgment. Psychol Rev. 1927;34:273–86.

    Article  Google Scholar 

  10. Devlin NJ, Krabbe PF. The development of new research methods for the valuation of EQ-5D-5L. Eur J Health Econ. 2013;14(Suppl 1):S1–3. doi:10.1007/s10198-013-0502-3.

    Article  PubMed  Google Scholar 

  11. Oppe M, Devlin NJ, van Hout B, Krabbe PF, de Charro F. A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. Value Health. 2014;17(4):445–53. doi:10.1016/j.jval.2014.04.002.

    Article  PubMed  Google Scholar 

  12. Ramos-Goñi JM, Rivero-Arias O, Errea M, Stolk EA, Herdman M, Cabases JM. Dealing with the health state ‘dead’ when using discrete choice experiments to obtain values for EQ-5D-5L heath states. Eur J Health Econ HEPAC Health Econ Prev Care. 2013;14(Suppl 1):S33–42. doi:10.1007/s10198-013-0511-2.

    Article  Google Scholar 

  13. Flynn T. Using conjoint analysis to estimate health state values for cost-utility analysis: issues to consider. Pharmacoeconomics. 2010;28(9):711–22.

    Article  PubMed  Google Scholar 

  14. Mulhern B, Bansback N, Brazier J, Buckingham K, Cairns J, Devlin N et al. Preparatory study for the revaluation of the EQ-5D tariff: methodology report. Health Technol Assess. 2014;18(12):vii–xxvi, 1–191. doi:10.3310/hta18120.

  15. Flynn TN, Louviere JJ, Marley AA, Coast J, Peters TJ. Rescaling quality of life values from discrete choice experiments for use as QALYs: a cautionary tale. Popul Health Metrics. 2008;6:6.

    Article  Google Scholar 

  16. Mulhern B, Longworth L, Brazier J, Rowen D, Bansback N, Devlin N, et al. Binary choice health state valuation and mode of administration: head-to-head comparison of online and CAPI. Value Health. 2013;16(1):104–13. doi:10.1016/j.jval.2012.09.001.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Street DJ, Burgess L. The construction of optimal stated choice experiments: theory and methods. Wiley series in probability and statistics. New Jersey: Wiley; 2007.

  18. Rand-Hendriksen K, Augestad LA, Dahl FA, Kristiansen IS, Stavem K. A shortcut to mean-based time tradeoff tariffs for the EQ-5D? Med Decis Making. 2012;32(4):569–77. doi:10.1177/0272989X11431607.

    Article  PubMed  Google Scholar 

  19. Tsuchiya A, Dolan P. The QALY model and individual preferences for health states and health profiles over time: a systematic review of the literature. Med Decis Making. 2005;25(4):460–7. doi:10.1177/0272989X05276854.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard Norman.

Ethics declarations

Conflict of interest

The authors (Norman, Mulhern, and Viney) declare no conflict of interests. Data collection was funded by a National Health and Medical Research Council Project Grant (403303).

Author contributions

Norman conceived and undertook the analysis, and was primarily responsible for drafting the manuscript. Mulhern helped to develop the approaches to anchoring explored in the analysis, and commented on and amended the draft manuscript. Viney was responsible for the design and collection of the underpinning data, and commented on and amended the draft manuscript.

Appendix

Appendix

Screenshots of the tasks in the two studies .

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Norman, R., Mulhern, B. & Viney, R. The Impact of Different DCE-Based Approaches When Anchoring Utility Scores. PharmacoEconomics 34, 805–814 (2016). https://doi.org/10.1007/s40273-016-0399-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40273-016-0399-7

Keywords

Navigation